Is DMRT2 p.Ala29Ser (c.85G>T) pathogenic?

DMRT2 p.Ala29Ser (c.85G>T) is classified Uncertain significance in DMRT2 (ClinVar, Multiple submitters, 2 submitters; last evaluated 2025-04-16). AlphaMissense: likely benign (0.0765); Ultra-rare (popmax 0.0209%, amr).

How common is DMRT2 p.Ala29Ser (c.85G>T) in the general population?

DMRT2 p.Ala29Ser (c.85G>T) is ultra-rare (popmax 0.0209%, amr) (gnomAD).

What do computational predictors say about DMRT2 p.Ala29Ser (c.85G>T)?

AlphaMissense predicts likely benign (score 0.0765) — an in-silico prediction, not a clinical call.

DMRT2 p.Ala29Ser

c.85G>T · rs997632409 · VCV1413724

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

AlphaMissense

likely benign

0.0765 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0209%, amr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0765	likely benign
REVEL	0.036	moderately benign-leaning
SaProt	LLR -4.93	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 2.1	GERP -2.8, phastCons 1
Regional constraint	o/e 1.42	unconstrained · MANE · 5,656 bp · p 7.1e-31 · regional, not allelic
Overall
CADD	9.451	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0209% Admixed American · 11/52,656 alleles

Filtering AF 0.0172% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0165%

Overall 0.0159% 247/1,555,590 alleles · ultra-rare exomes 216/1,403,362 · genomes 31/152,228 · joint denominator

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.0209%	4,787
European (non-Finnish)	0.0194%	5,167
Middle Eastern	0.0168%	5,944
Remaining individualsnot grpmax-eligible	0.0116%	8,646
African / African-American	0.00418%	23,931
Finnishnot grpmax-eligible	0.00195%	51,252

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: DMRT2
Protein: p.Ala29Ser
Coding: c.85G>T
MANE Select: NM_181872
dbSNP: rs997632409
Type: single nucleotide variant
Location: chr9:1051698 (GRCh38)
Gene constraint: LOEUF 1.279 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure: AlphaFold pLDDT 54.37
Residue 29: the 'disordered' region

Full DMRT2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

DMRT2 p.Ala112Glu Uncertain significance ★★ ⚠ same type
DMRT2 p.Asp176Gly Uncertain significance ★★ ⚠ same type
DMRT2 p.Asp48Glu Uncertain significance ★★ ⚠ same type
DMRT2 p.Cys105Tyr Uncertain significance ★★ ⚠ same type
DMRT2 p.Glu60Gln Uncertain significance ★★ ⚠ same type
DMRT2 p.Gly110Asp Uncertain significance ★★ ⚠ same type
DMRT2 p.Gly36Arg Uncertain significance ★★ ⚠ same type
DMRT2 p.Gly73Arg Uncertain significance ★★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dmrt2-p-ala29ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown